| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.6 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |